Literature DB >> 23946045

Management of neonatal jaundice varies by practitioner type.

Patrocinio C Mateo1, Kyong-Soon Lee, Matthew Barozzino, Michael Sgro.   

Abstract

OBJECTIVE: To survey current practices among different types of medical practitioners in Ontario to assess if national guidelines for screening and management of neonatal hyperbilirubinemia were being followed.
DESIGN: An anonymized, cross-sectional survey distributed by mail and e-mail.
SETTING: Ontario. PARTICIPANTS: From each group (general practitioners, family medicine practitioners, and pediatricians), 500 participants were randomly selected, and all 390 registered midwives were selected. MAIN OUTCOME MEASURES: Compliance with national guidelines for screening, postdischarge follow-up, and management of newborns with hyperbilirubinemia.
RESULTS: Of the 1890 potential respondents, 321 (17%) completed the survey. Only 41% of family physicians reported using national guidelines, compared with 75% and 69% of pediatricians and midwives, respectively (P < .001). Bilirubin was routinely measured for all newborns before discharge by 42% of family physicians, 63% of pediatricians, and 22% of midwives (P < .001). Newborn follow-up was completed within 72 hours after discharge by 60% of family physicians, 89% of pediatricians, and 100% of midwives. Management of neonatal hyperbilirubinemia differed significantly (P < .001), with 91% of family physicians, 99% of pediatricians, and 79% of midwives correctly managing a case scenario according to the guidelines.
CONCLUSION: The management of jaundice varied considerably among the different practitioner types, with pediatricians both most aware of the guidelines and most likely to follow them. Increased knowledge translation efforts are required to promote adherence to the jaundice management guidelines across all practitioner types, but particularly among family physicians.

Entities:  

Mesh:

Year:  2013        PMID: 23946045      PMCID: PMC3743715     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  22 in total

1.  Increased neonatal readmission rate associated with decreased length of hospital stay at birth in Canada.

Authors:  S Liu; S W Wen; D McMillan; K Trouton; D Fowler; C McCourt
Journal:  Can J Public Health       Date:  2000 Jan-Feb

Review 2.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

3.  System-based approach to management of neonatal jaundice and prevention of kernicterus.

Authors:  Lois H Johnson; Vinod K Bhutani; Audrey K Brown
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

Review 4.  Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus.

Authors:  Vinod K Bhutani; Lois H Johnson
Journal:  Clin Chem       Date:  2004-01-15       Impact factor: 8.327

Review 5.  Diagnosis and management of hyperbilirubinemia in the term neonate: for a safer first week.

Authors:  Vinod K Bhutani; Lois H Johnson; Ron Keren
Journal:  Pediatr Clin North Am       Date:  2004-08       Impact factor: 3.278

6.  Practice patterns in neonatal hyperbilirubinemia.

Authors:  L M Gartner; C T Herrarias; R H Sebring
Journal:  Pediatrics       Date:  1998-01       Impact factor: 7.124

7.  Guideline adherence in ectopic pregnancy management.

Authors:  F Mol; E van den Boogaard; N M van Mello; F van der Veen; B W Mol; W M Ankum; P van Zonneveld; A B Dijkman; H R Verhoeve; A Mozes; M Goddijn; P J Hajenius
Journal:  Hum Reprod       Date:  2010-12-02       Impact factor: 6.918

8.  Antimicrobial use for pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs.

Authors:  R L Watson; S F Dowell; M Jayaraman; H Keyserling; M Kolczak; B Schwartz
Journal:  Pediatrics       Date:  1999-12       Impact factor: 7.124

9.  Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline?

Authors:  Lee R Atkinson; Gabriel J Escobar; John I Takayama; Thomas B Newman
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

10.  Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Authors: 
Journal:  Pediatrics       Date:  2004-07       Impact factor: 7.124

View more
  4 in total

1.  A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion.

Authors:  Bolajoko O Olusanya; Folashade B Osibanjo; Adeniyi A Ajiboye; Oluwafemi E Ayodele; Adebanke A Odunsi; Serah M Olaifa; Abieyuwa A Emokpae
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-20

2.  Evaluation of auditory brain stems evoked response in newborns with pathologic hyperbilirubinemia in mashhad, iran.

Authors:  Tooba Okhravi; Saeedeh Tarvij Eslami; Ali Hushyar Ahmadi; Hossain Nassirian; Reza Najibpour
Journal:  Iran Red Crescent Med J       Date:  2015-02-04       Impact factor: 0.611

3.  Adherence to hyperbilirubinemia guidelines by midwives, general practitioners, and pediatricians in Indonesia.

Authors:  Mahendra T A Sampurna; Kinanti A Ratnasari; Risa Etika; Christian V Hulzebos; Peter H Dijk; Arend F Bos; Pieter J J Sauer
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

4.  Assessment of adherence level for neonatal hyperbilirubinemia management by various physicians in ‎Iraq: a multi-clinic study.

Authors:  Numan Nafie Hameed; Hikmat Noori Yousif; Hayder Adnan Fawzi
Journal:  F1000Res       Date:  2020-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.